Abstract
The beta-adrenergic antagonist, alprenolol, was attached in an irreversible manner to macromolecular dextran via side arms that differed in length. The ability of these macromolecules to bind to the beta-adrenergic receptor of frog erythrocytes and to catecholamine-binding antibodies raised against partially purified receptors was studied. Compared to the parent drug the potency of binding of macromolecular alprenolol to the receptor decreased about 1/10, 1/600, and 1/8000 when the length of the arm separating alprenolol from the dextran moiety was 13, 8, and 4 atoms, respectively. In contrast, the binding potencies of the parent drug and of all its macromolecular derivatives for the antibody were within the same order of magnitude. Thus, conversion of a drug to a macromolecular form may not only sustain its binding activity but may also lead in a higher selectivity. The macromolecular derivatives described here may be suitable probes for investigation of the location and of the molecular properties of the binding sites for beta-adrenergic drugs.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atlas D., Yaffe D., Skutelsky E. Ultrastructural probing of beta-adrenoreceptors on cell surfaces. FEBS Lett. 1978 Nov 1;95(1):173–176. doi: 10.1016/0014-5793(78)80077-5. [DOI] [PubMed] [Google Scholar]
- Bar R. S., Harrison L. C., Muggeo M., Gorden P., Kahn C. R., Roth J. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med. 1979;24:23–52. [PubMed] [Google Scholar]
- Bartsch W., Dietmann K., Leinert H., Sponer G. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers. Arzneimittelforschung. 1977;27(5):1022–1026. [PubMed] [Google Scholar]
- Caron M. G., Lefkowitz R. J. Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes. J Biol Chem. 1976 Apr 25;251(8):2374–2384. [PubMed] [Google Scholar]
- Caron M. G., Srinivasan Y., Pitha J., Kociolek K., Lefkowitz R. J. Affinity chromatography of the beta-adrenergic receptor. J Biol Chem. 1979 Apr 25;254(8):2923–2927. [PubMed] [Google Scholar]
- Caron M. G., Srinivasan Y., Snyderman R., Lefkowitz R. J. Antibodies raised against purified beta-adrenergic receptors specifically bind beta-adrenergic ligands. Proc Natl Acad Sci U S A. 1979 May;76(5):2263–2267. doi: 10.1073/pnas.76.5.2263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chu B. C., Whiteley J. M. High molecular weight derivatives of methotrexate as chemotherapeutic agents. Mol Pharmacol. 1977 Jan;13(1):80–88. [PubMed] [Google Scholar]
- Cuatrecasas P. Affinity chromatography. Annu Rev Biochem. 1971;40:259–278. doi: 10.1146/annurev.bi.40.070171.001355. [DOI] [PubMed] [Google Scholar]
- Hammond J. J., Kirkendall W. M. Antihypertensive drugs for the aging. Geriatrics. 1979 Jun;34(6):27–36. [PubMed] [Google Scholar]
- Kågedal L., Akerström S. Binding of covalent proteins to polysaccharides by cyanogen bromide and organic cyanates. I. Preparation of soluble glycine-, insulin- and ampicillin-dextran. Acta Chem Scand. 1971;25(5):1855–1859. doi: 10.3891/acta.chem.scand.25-1855. [DOI] [PubMed] [Google Scholar]
- Lefkowitz R. J., Limbird L. E., Mukherjee C., Caron M. G. The beta-adrenergic receptor and adenylate cyclase. Biochim Biophys Acta. 1976 Apr 13;457(1):1–39. doi: 10.1016/0304-4157(76)90012-5. [DOI] [PubMed] [Google Scholar]
- Melmon K. L., Weinstein Y., Bourne H. R., Poon T., Shearer G., Castagnoli N., Jr The pharmacological effects of conjugates of pharmacologically active amines to complex or simple carriers: a new class of drug. Mol Pharmacol. 1976 Sep;12(5):701–710. [PubMed] [Google Scholar]
- Mukherjee C., Caron M. G., Mullikin D., Lefkowitz R. J. Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies. Mol Pharmacol. 1976 Jan;12(1):16–31. [PubMed] [Google Scholar]
- Noronha-Blob L., Vengris V. E., Pitha P. M., Pitha J. Uptake and fate of water-soluble, nondegradable polymers with antiviral activity in cells and animals. J Med Chem. 1977 Mar;20(3):356–359. doi: 10.1021/jm00213a009. [DOI] [PubMed] [Google Scholar]
- Ohno K., Pettigrew K. D., Rapoport S. I. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol. 1978 Sep;235(3):H299–H307. doi: 10.1152/ajpheart.1978.235.3.H299. [DOI] [PubMed] [Google Scholar]
- Pitha J. Reagents specific for cell surface components. Eur J Biochem. 1978 Jan 2;82(1):285–292. doi: 10.1111/j.1432-1033.1978.tb12022.x. [DOI] [PubMed] [Google Scholar]
- Rzeszotarski W. J., Gibson R. E., Eckelman W. C., Reba R. C. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols. J Med Chem. 1979 Jun;22(6):735–737. doi: 10.1021/jm00192a022. [DOI] [PubMed] [Google Scholar]
- Streefkerk D. G., Manjula B. N., Glaudemans C. P. An interpretation of the apparent dual specificity of some murine myeloma immunoglobulins with inulinbinding activity. J Immunol. 1979 Feb;122(2):537–541. [PubMed] [Google Scholar]
- Vauquelin G., Geynet P., Hanoune J., Strosberg A. D. Isolation of adenylate cyclase-free, beta-adrenergic receptor from turkey erythrocyte membranes by affinity chromatography. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3710–3714. doi: 10.1073/pnas.74.9.3710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verlander M. S., Venter J. C., Goodman M., Kaplan N. O., Saks B. Biological activity of catecholamines covalently linked to synthetic polymers: proof of immobilized drug theory. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1009–1013. doi: 10.1073/pnas.73.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
